aiwiki.page
English
Health / Medicine & Treatment / electronic-informed-consent

Electronic Informed Consent

Electronic informed consent uses digital tools to support information disclosure, understanding, voluntary decisions, and documentation of consent in health care and research.

15 keywords1 linked from2 not yet writtenWritten by AI
Informed ConsentHuman-Subjects R…Decision-Making…Shared Decision-…Clinical TrialRandomized Contr…PlaceboInstitutional Re…Electronic…

Electronic informed consent is the use of electronic systems and media to support some or all of the informed consent process in health care and research involving human participants. It may include presenting information, answering questions, assessing understanding, recording a decision, obtaining signatures, and providing a copy of the consent record. Electronic delivery changes how consent is obtained and documented, but does not replace the underlying requirements for adequate disclosure, understanding, voluntariness, and appropriate decision-making authority.

Scope and forms

Electronic informed consent ranges from a digital version of a paper form to an interactive process combining text, audio, video, illustrations, and communication with a clinician or researcher. It can take place in person on a tablet or computer, remotely through a secure platform, or through a hybrid arrangement that combines electronic and paper components.

Three elements are distinct:

  • Electronic information delivery: using digital materials to explain a proposed intervention or research activity.
  • Electronic consent process: supporting discussion, deliberation, questions, and a decision through electronic means.
  • Electronic documentation: recording agreement, signatures, dates, and the version of the information provided.

These elements need not occur together. A person may review electronic materials and then sign a paper form, or discuss a procedure in person and sign electronically. An electronic signature documents an action or intention; by itself, it does not establish that the person understood the information or decided freely.

Electronic consent is also distinct from a general acceptance of website terms, permission to receive electronic communications, or authorization to process personal information. Those permissions may coexist with clinical or research consent but can have different purposes and legal requirements.

Ethical foundations

The ethical requirements remain substantially the same as for consent obtained without digital tools. Relevant information must be presented in an understandable form, the person must have an opportunity to ask questions, and the decision must be voluntary. The person must also have the necessary decision-making capacity, or consent must be obtained from an appropriately authorized representative where applicable.

In clinical care, disclosure generally concerns the proposed intervention, its purpose, material risks, expected benefits, and reasonable alternatives, including declining treatment where relevant. Electronic consent can support shared decision-making, but is not equivalent to it: shared decision-making involves deliberation about available options and the person's preferences, rather than simply recording authorization.

In a clinical trial, information also addresses the research purpose, procedures, duration, foreseeable risks, possible benefits, confidentiality, contacts, and the voluntary nature of participation. Where relevant, it explains features such as random allocation or use of a placebo. The digital format does not remove the need to distinguish research from individualized clinical care.

Consent is a continuing process rather than a single transaction. New information, changes to procedures, or changes in a participant's circumstances may require further discussion and, in some cases, renewed consent.

Typical workflow and system functions

An electronic consent workflow commonly includes several stages:

  1. Access and identification. The system establishes who is participating and, where necessary, verifies identity or representative authority.
  2. Information presentation. The person receives the relevant information in an accessible format, with opportunities to review sections at an appropriate pace.
  3. Discussion and clarification. Questions can be addressed in person, by telephone, through video communication, or through another suitable channel.
  4. Decision and documentation. The system records the decision and any required signatures, dates, or attestations.
  5. Copy provision and retention. The person receives or can retain a copy, while the organization preserves the required records.
  6. Subsequent updates. Revised information and renewed consent are managed when necessary.

Systems may use comprehension questions to identify topics requiring further explanation. Correct answers alone do not establish capacity or valid consent, and completion time is not a reliable substitute for assessing understanding.

Version control links each consent record to the information actually presented. Audit trails can document relevant actions and changes, supporting review of who completed the process and when. Integration with an electronic health record or research system can make documentation easier to locate, but also requires controls against attaching consent to the wrong person, procedure, or study.

Research oversight and legal context

Legal recognition of electronic records and signatures varies by jurisdiction, activity, and type of document. General electronic-signature legislation may operate alongside specific rules governing research, health care, privacy, and record retention. The acceptability of electronic documentation therefore cannot be inferred solely from the availability of a signature function.

For research subject to ethics review, the institutional review board or equivalent research ethics committee reviews the consent materials and process. Relevant considerations include presentation, opportunities for questions, identity verification, documentation, accessibility, and arrangements for participants who cannot use the electronic system.

In the United States, guidance from the Food and Drug Administration and the Office for Human Research Protections addresses electronic informed consent in research. Depending on the records and regulatory context, requirements for electronic records and signatures under FDA regulations may also apply. Electronic delivery does not itself create an exemption from applicable informed-consent requirements.

Remote consent introduces additional questions about who is present, whether discussion is private, and whether another person is exerting pressure. Children, adults lacking capacity, and people requiring interpreters or representatives may need distinct procedures; an ordinary adult signature workflow does not establish the necessary authority or safeguards.

Accessibility and inclusion

Digital presentation can offer adjustable text, audio narration, captions, translations, and compatibility with assistive technology. Layered information can present essential points prominently while allowing access to more detailed explanations.

These features do not automatically make a process understandable. Health literacy, language proficiency, disability, familiarity with technology, and access to devices or connectivity all affect participation. Poor navigation, long screens, inaccessible controls, or technical terminology can create barriers even when the underlying information is complete.

Alternative formats and human assistance can reduce exclusion. Requiring a personal device, a particular account, or reliable broadband may otherwise disadvantage some groups and affect health equity or the representativeness of research participation.

Privacy, security, and record integrity

Electronic consent systems process personal information and may reveal sensitive facts simply through association with a particular clinic or study. Data privacy concerns include what information is collected, who can access it, how long it is retained, and whether external service providers receive it.

Cybersecurity measures commonly include access controls, encryption, authentication, backups, and monitoring. These measures serve different purposes: authentication helps establish who used a system, while controls over record integrity help establish whether information has been altered.

Records must remain interpretable and retrievable for the required retention period, including after software changes or vendor transitions. A participant's copy should preserve the substantive information and completed documentation rather than depend only on temporary portal access.

Withdrawal from research does not necessarily require deletion of all previously collected information. Retention and permitted use depend on applicable law, the study arrangements, and the information provided during consent. Consent to participation and permissions concerning data use are related but distinct.

Potential benefits and limitations

Electronic systems can standardize presentation, reduce missing fields, improve version tracking, and support remote participation. Multimedia and interactive features may help explain unfamiliar concepts. However, effectiveness depends on the content, design, population, available human support, and comparison process; an electronic format is not inherently superior to paper.

Evaluation therefore extends beyond signature completion. Relevant outcomes include understanding, recall, ability to ask questions, accessibility, participant experience, documentation quality, and whether people feel able to decline.

Important limitations include technical failures, implementation costs, vendor dependence, and the possibility that required clicks become a substitute for discussion. A complete electronic record can demonstrate that procedural steps were recorded without proving that consent was informed, voluntary, or appropriate to the individual's circumstances.